The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, but its future within the broader industry now triggers questions about long-term yields . Alternative versions are diminishing exclusivity , prompting anxieties that supporting companies closely tied to Viagra's previous influence could be a dangerous decision